Russell Investments Group Ltd. Increases Stock Position in Quantum-Si Incorporated $QSI

Russell Investments Group Ltd. raised its position in shares of Quantum-Si Incorporated (NASDAQ:QSI) by 322.6% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 38,257 shares of the company’s stock after buying an additional 29,204 shares during the period. Russell Investments Group Ltd.’s holdings in Quantum-Si were worth $46,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in QSI. Nuveen LLC purchased a new stake in Quantum-Si during the 1st quarter valued at $383,000. Two Sigma Investments LP purchased a new stake in Quantum-Si during the 4th quarter valued at $412,000. Centiva Capital LP purchased a new stake in Quantum-Si during the 4th quarter valued at $387,000. XTX Topco Ltd boosted its position in Quantum-Si by 50.2% during the 1st quarter. XTX Topco Ltd now owns 368,968 shares of the company’s stock valued at $443,000 after buying an additional 123,383 shares during the period. Finally, Green Alpha Advisors LLC raised its holdings in Quantum-Si by 53.6% in the 1st quarter. Green Alpha Advisors LLC now owns 244,067 shares of the company’s stock worth $293,000 after purchasing an additional 85,209 shares in the last quarter. Hedge funds and other institutional investors own 39.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have commented on QSI. Alliance Global Partners restated a “buy” rating on shares of Quantum-Si in a report on Friday, May 16th. HC Wainwright restated a “buy” rating and issued a $5.50 price objective on shares of Quantum-Si in a report on Monday, May 19th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $3.48.

Insider Transactions at Quantum-Si

In other Quantum-Si news, CEO Jeffrey Alan Hawkins sold 23,705 shares of the business’s stock in a transaction dated Monday, June 23rd. The stock was sold at an average price of $1.61, for a total transaction of $38,165.05. Following the completion of the sale, the chief executive officer directly owned 2,623,011 shares in the company, valued at $4,223,047.71. The trade was a 0.90% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider John S. Vieceli sold 21,923 shares of the business’s stock in a transaction dated Monday, June 23rd. The shares were sold at an average price of $1.61, for a total value of $35,296.03. Following the sale, the insider owned 842,586 shares of the company’s stock, valued at approximately $1,356,563.46. This represents a 2.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 54,252 shares of company stock valued at $87,346. Corporate insiders own 30.04% of the company’s stock.

Quantum-Si Price Performance

Shares of Quantum-Si stock opened at $1.07 on Friday. The stock has a market cap of $216.66 million, a price-to-earnings ratio of -1.57 and a beta of 2.85. The firm’s 50-day moving average is $1.50 and its 200 day moving average is $1.47. Quantum-Si Incorporated has a 1 year low of $0.61 and a 1 year high of $5.77.

Quantum-Si (NASDAQ:QSI) last announced its quarterly earnings results on Tuesday, August 5th. The company reported ($0.16) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.16). The company had revenue of $0.59 million for the quarter, compared to analysts’ expectations of $1.28 million. Quantum-Si had a negative net margin of 3,120.14% and a negative return on equity of 44.57%. On average, equities analysts expect that Quantum-Si Incorporated will post -0.65 EPS for the current fiscal year.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.